Financing Round Adds $39 Million to VitalConnect Coffers

VitalConnect Inc., is $39 million in the black, thanks to its latest financing round.

Investors include EW Healthcare Partners and other new and existing supporters. As a condition of the financing, EW Healthcare Operating Partner Robert S. White has joined VitalConnect’s Board of Directors. White has more than 30 years’ experience leading early-stage companies and business units of Fortune 500 companies within the medical technology sector. He also has significant experience in medical devices and cardiology.

“We believe the VitalConnect platform will transform the way patient care is delivered by providing physicians with real-time, and more comprehensive, insights into the health of their patients in ways never experienced before,” said White. “I look forward to working with the team at VitalConnect to accelerate the company’s growth.”
 
VitalConnect plans to use the money raised in this financing round to expand its commercial team, scale operations, and develop new products to help drive top-line growth and continue bringing the best technology to patients and providers.
 
“This latest round of financing will help VitalConnect continue our upward trajectory in cardiac monitoring spaces,” VitalConnect CEO Peter Van Haur said. “We’ve experienced significant growth and rapid physician adoption over the past year and with the help of our investors we will continue to bring customers the most comprehensive, remote patient monitoring platform on the market.”
 
Founded in 2011, VitalConnect has deployed more than 200,000 patches throughout the world, including care facilities such as Brigham and Women’s, Hackensack Medical Center, Northwell Health, and John Radcliffe Hospital-Oxford University. The VitalPatch allows real-time remote or in-hospital monitoring, allowing physicians to optimize the delivery of care to their patients.
 
VitalConnect is a leader in wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations. VitalConnect leverages expertise in biomedical engineering, data analytics, chip design, and mobile and cloud software to create technology that supports decision-making paradigms that achieve better health and economic outcomes. VitalConnect’s products are designed for use in a broad range of inpatient and outpatient settings, such as hospital monitoring, post-discharge care, cardiac monitoring and pharmaceutical solutions. 
 
EW Healthcare Partners is one of the largest and oldest private healthcare investment firms and seeks to make growth equity investments in fast growing commercial-stage healthcare companies in the pharmaceutical, medtech, and technology-enable services sectors in the United States and in Europe. Since its founding in 1985, EW Healthcare Partners has maintained its singular commitment to the healthcare industry and has been a long-term investor in over 150 healthcare companies, ranging across sectors, stages and geographies. The team is comprised of over 20 investment professionals with offices in Houston, New York, and London.